| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income, net | 6,656 | 7,419 | 8,363 | 9,596 |
| Net loss before income tax provision | -58,895 | -79,183 | -61,841 | -54,250 |
| Provision for (benefit from) income taxes | 205 | -231 | -1,087 | -3,448 |
| Net loss | -59,100 | -78,952 | -60,754 | -50,802 |
| Foreign currency translation adjustment | -108 | -1,902 | -1,580 | -2,093 |
| Total comprehensive loss | -59,208 | -80,854 | -62,334 | -52,895 |
| Earnings per share, basic | -0.85 | -1.14 | -0.88 | -0.74 |
| Earnings per share, diluted | -0.85 | -1.14 | -0.88 | -0.74 |
| Weighted average number of shares outstanding, basic | 69,303,746 | 69,252,009 | 69,196,945 | 68,988,858 |
| Weighted average number of shares outstanding, diluted | 69,303,746 | 69,252,009 | 69,196,945 | 68,988,858 |
BICYCLE THERAPEUTICS PLC (BCYC)
BICYCLE THERAPEUTICS PLC (BCYC)